← back to search

Amber C. Donahue

Ideaya Biosciences (United States) · US
Area of research
Hematology · Genetics
Research interest
Research interests include Acute Myeloid Leukemia Research, Chronic Lymphocytic Leukemia Research, Cancer Genomics and Diagnostics, and Ubiquitin and proteasome pathways.
h-index
17
citations
1,284
works
47
NIH funding
primary concept
Medicine
email

Recent publications

Avelumab plus axitinib versus sunitinib in advanced renal cell carcinoma: biomarker analysis of the phase 3 JAVELIN Renal 101 trial
Nature Medicine 2020cited by 515position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

Toni K. Choueiri · Harvard University1 papers (2020–2020)Robert J. Motzer · Texas Oncology1 papers (2020–2020)Paul B. Robbins · Allogene Therapeutics (United States)1 papers (2020–2020)Jae‐Lyun Lee · Ulsan College1 papers (2020–2020)Gwénaëlle Gravis · University College London1 papers (2020–2020)Laurence Albigès · Institut Gustave Roussy1 papers (2020–2020)James Larkin · Trinity College Dublin1 papers (2020–2020)Jing Wang · Yangzhou Vocational University1 papers (2020–2020)Weidong Zhang · Takeda (Japan)1 papers (2020–2020)Motohide Uemura · Osaka University Hospital1 papers (2020–2020)Thomas Powles · Twitter (United States)1 papers (2020–2020)Aleksander Chudnovsky · Pfizer (United States)1 papers (2020–2020)Alessandra di Pietro · Pfizer (Italy)1 papers (2020–2020)Xiao Wang · Chinese Center For Disease Control and Prevention1 papers (2020–2020)Matthew T. Campbell · The University of Texas MD Anderson Cancer Center1 papers (2020–2020)John B.A.G. Haanen · Nikki-Universal (Japan)1 papers (2020–2020)Konstantin Penkov · City Clinical Hospital No 311 papers (2020–2020)B. Yа. Alekseev · Ministry of Health1 papers (2020–2020)Keith A. Ching · Pfizer (United States)1 papers (2020–2020)Xinmeng Jasmine Mu · Broad Institute1 papers (2020–2020)